DRMA
Dermata Therapeutics, Inc.
$1.34
+0.00 (+0.00%)
At close · Jul 6
Market Cap
$5.39M
Shares
4,022,143
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Brittany Bradrick | Class II director | Appointed | 2026-05-27 |
| Steven Mento, Ph.D. | Class II director | Appointed | 2026-05-27 |
| David Hale | Class II director | Appointed | 2026-05-27 |